Show simple item record

dc.contributor.authorGurung, Khum
dc.contributor.authorNcibi, Mohamed Chaker
dc.contributor.authorThangaraj, Senthil K
dc.contributor.authorJänis, Janne
dc.contributor.authorSeyedsalehi, Mahdi
dc.contributor.authorSillanpää, Mika
dc.date.accessioned2019-04-09T11:03:14Z
dc.date.available2019-04-09T11:03:14Z
dc.date.issued2019
dc.identifier.urihttps://erepo.uef.fi/handle/123456789/7525
dc.description.abstractPharmaceutically active compounds (PhACs) are emerging pollutants causing serious challenges to wastewater treatment plants due to poor biodegradability. In this study, the enhanced removal of highly recalcitrant and commonly monitored PhACs, carbamazepine (CBZ) and diclofenac (DCF) by heterogeneous photocatalysis was investigated using 5% Ag2O/P-25 photocatalyst. The photocatalyst was characterized by scanning electron microscope (SEM-EDX), Brunauer-Emmett-Teller (BET), Fourier transfer infrared spectroscopy (FTIR) and UV–vis diffuse reflectance spectra (UV-DRS). The effects of catalyst dose, initial pollutants concentration, and mineralization during the photocatalytic degradation of PhACs were investigated. The matrix effect was assessed in deionized water (DW) and real membrane bioreactor effluent (RME). Optimal CBZ and DCF removals of 89.10% and 93.5%, respectively for 180 min of UV irradiation were achieved at catalyst dosage of 0.4 g L−1 in DW matrix. However, the optimal catalyst dosages for CBZ and DCF in RME matrix were increased by factor 2 and 1.5, respectively, to achieve the same degree of removal. Declining trends of removal rate were observed when initial concentrations of both the PhACs were increased under optimal catalyst dosages, and kinetics seem to fit the Langmuir-Hinshelwood model. Photo-induced holes and OH were the dominant oxidation species involved in the photocatalytic degradation of the PhACs. A plausible reusability of 5% Ag2O/P-25 photocatalyst was observed for both the PhACs. Moreover, various aromatic/aliphatic intermediates generated during the photodegradation CBZ were identified using fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometry, and a possible multi-step degradation pathway was proposed. Overall, the removal of PhACs using 5% Ag2O/P-25 photocatalyst showed promising results in real wastewater.
dc.language.isoenglanti
dc.publisherElsevier BV
dc.relation.ispartofseriesSeparation and purification technology
dc.relation.urihttp://dx.doi.org/10.1016/j.seppur.2018.12.069
dc.rightsCC BY-NC-ND https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectPhACs
dc.subjectphotocatalytic degradation
dc.subjectAg2O/P-25 photocatalysts
dc.subjectmatrix effect
dc.subjecttransformation products
dc.titleRemoval of pharmaceutically active compounds (PhACs) from real membrane bioreactor (MBR) effluents by photocatalytic degradation using composite Ag2O/P-25 photocatalyst
dc.description.versionfinal draft
dc.contributor.departmentDepartment of Chemistry, activities
uef.solecris.id61278989en
dc.type.publicationTieteelliset aikakauslehtiartikkelit
dc.rights.accessrights© Elsevier B.V.
dc.relation.doi10.1016/j.seppur.2018.12.069
dc.description.reviewstatuspeerReviewed
dc.format.pagerange317-328
dc.publisher.countryAlankomaat
dc.relation.issn1383-5866
dc.relation.volume215
dc.rights.accesslevelopenAccess
dc.type.okmA1
uef.solecris.openaccessEi


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record